Tag Archives: Product

Illnesses Attributed to Monsanto’s Roundup Weed Killer Trigger Widespread Product Liability Litigation

Environmental Protection Agency Still Not Convinced of Its Carcinogenic Properties Roundup Weed Killer is a pesticide developed by Monsanto Company that contains the active ingredient glyphosate. Millions of tons of Roundup have been used in residential, municipal, industrial and agricultural … Continue reading

Posted in Medical malpractice law | Tagged , , , , , , , , , , | Leave a comment

Chief Judge Stark Denies Wabtec’s Motion for Preliminary Injunction Seeking to Enjoin Alleged Infringement through Sale of Competitive Product

By Memorandum entered by The Honorable Leonard P. Stark in Westinghouse Air Brake Technologies Corp. v. Siemens Industry Inc., Civil Action No. 17-1687-LPS (D.Del. August 2, 2018), the Court denied Plaintiff Westinghouse Air Brake Technologies Corporation’s (d/b/a Wabtec Corporation) Motion … Continue reading

Posted in Intellectual Property | Tagged , , , , , , , , , , , , , , , | Leave a comment

On the merger paradox and asymmetric product differentiation

Tsuyoshi Toshimitsu (School of Economics, Kwansei Gakuin University) and Tetsuya Nakajima (Faculty of Economics, Osaka City University) provide thoughts On the merger paradox and asymmetric product differentiation. ABSTRACT: Assuming asymmetric product differentiation, we reconsider the merger paradox in the cases… … Continue reading

Posted in Antitrust - Competition law | Tagged , , , , | Leave a comment

ESMA updates MiFID II Q&As on temporary product intervention measures

On 30 July 2018, the European Securities and Markets Authority (ESMA) published an updated version of its Q&As on temporary product intervention measures on the marketing, distribution or sale of contracts for differences (CFDs) and binary options (BO) to retail … Continue reading

Posted in Banking and Finance law | Tagged , , , , , , , | Leave a comment

Court of Federal Claims Sides with Company in Bid Protest Over Interpretation of the Trade Agreements Clause in a Solicitation for a Pharmaceutical Product

By Michelle L. Butler & Alan M. Kirschenbaum — On July 10, 2018, the Court of Federal Claims found the Department of Veterans Affairs’ (“VA’s”) interpretation of the Trade Agreements clause to be arbitrary and capricious in Acetris Health, LLC … Continue reading

Posted in Products Liability | Tagged , , , , , , , , , , , , , | Leave a comment